PHADIA US INC

Phadia US Inc specializes in the manufacturing and support of in-vitro diagnostic substances and associated laboratory systems, primarily serving military and veteran healthcare networks. The company delivers critical allergy and immunology testing reagents, including Immunocap-specific analytes, and provides maintenance for precision diagnostic equipment such as the Thermo Fisher Helios and ImmunoCAP systems. Their technical expertise lies in immunoassay-based diagnostics, automated analyzer integration, and the sustained operation of clinical laboratory platforms used for IgE, ANA, and galactose testing. A key differentiator is their direct support of proprietary diagnostic hardware and consumables, ensuring continuity of care in deployed and fixed medical facilities through tightly integrated test systems and on-site analyzer management. The contractor maintains a strong, recurring relationship with the Department of Defense, supplying diagnostic reagents and maintaining testing infrastructure at major military medical centers such as Wilford Hall Ambulatory Surgical Center. They also serve the Department of Veterans Affairs with both diagnostic substance procurement and precision equipment repair, indicating a dual role as supplier and service provider for clinical laboratory systems. Their work supports point-of-care and centralized lab testing environments critical to troop readiness and veteran health outcomes. Phadia US Inc operates primarily under NAICS 325413, focusing on the production of diagnostic substances used in clinical immunology and allergy testing. This positions them as a niche supplier within the medical diagnostics supply chain, with deep specialization in immunoassay technologies and analyzer-compatible reagents. Their market presence is defined by reliability in sustaining high-complexity testing workflows under stringent operational standards. As a 2L entity based in Portage, Michigan, Phadia US Inc is a mid-sized manufacturer with no federal certifications listed. Their geographic footprint is centered on supporting federal medical facilities nationwide, particularly those requiring sustained diagnostic capacity for immunological monitoring. They are positioned as a trusted provider of mission-critical diagnostic solutions for government healthcare operations.